Empowering Better Health

e4health tackles data, quality, and revenue challenges empowering your teams to focus on better care.

Our Leaders

Expertise: Webinars and White Papers



Upcoming Events

News & Blog

Taking care of the business and quality of healthcare

e4health cares for the quality, data, and results of your healthcare, so that you can care for your patients.

Health IT Consulting

Enterprise Program Management and Governance

Legacy Data Migration and Validation

Legacy System Support

IT and Project Team Staffing

Clinical Informatics Solutions

Data Analytics

Testing Management and Coordination

Go-Live Support

Mid-Revenue Cycle


Risk Adjustment and HCCs

Education and Training

Health Information Management

eMPI Remediation and Ongoing Management

Clinical Data Abstraction

Legacy Data Migration and Validation

Document Management

Interim Leadership and Staffing


Software Solutions

AI and Automation Solutions
Prostatic Artery Embolization

New code for Prostatic Artery Embolization under root operation (Occlusion)

benefits prostate artery embolizationFor 2023, a new code was introduced for Prostatic Artery Embolization (PAE) under root operation (Occlusion). It is in the same body system, Lower Arteries, as Uterine Artery Embolization. PAE helps improve benign prostatic hyperplasia (BPH) symptoms by blocking blood flow to areas of the prostate most affected by BPH. This results in the necrosis of the isolated regions. These areas of necrosis cause the prostate to initially be softer, alleviating some of the pressure that is causing blockage of the urine. Over several months, the body’s immune system reabsorbs the dead tissue and replaces it with a scar. This scar tissue slowly contracts to result in shrinkage of the prostate. Over six months, the prostate will shrink by 20-40%, resulting in improved and less frequent urination. Amazing technology!